Brain mitochondrial impairment in early‐onset Parkinson's disease with or without PINK1 mutation
Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations. Methods We investigated brain intracellular pH, mitochondrial activity...
Saved in:
Published in | Movement disorders Vol. 35; no. 3; pp. 504 - 507 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.03.2020
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0885-3185 1531-8257 1531-8257 |
DOI | 10.1002/mds.27946 |
Cover
Loading…
Abstract | Background
PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations.
Methods
We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.
Results
The EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−.
Conclusions
Brain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society |
---|---|
AbstractList | BackgroundPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations.MethodsWe investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.ResultsThe EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−.ConclusionsBrain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations.BACKGROUNDPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations.We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.METHODSWe investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate.The EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-.RESULTSThe EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-.Brain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society.CONCLUSIONSBrain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society. PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset Parkinson's disease, with or without PINK1 mutations. We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early-onset Parkinson's disease with PINK1 mutations (n = 10), early-onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex- and age-matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate. The EOPD- group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD-. Brain mitochondrial impairments were similar in early-onset Parkinson's disease without PINK1 mutations and late-onset Parkinson's disease. However, mitochondrial impairments were more severe in early-onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society. Background PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early‐onset Parkinson's disease, with or without PINK1 mutations. Methods We investigated brain intracellular pH, mitochondrial activity, and energetics with functional magnetic resonance spectroscopy in patients with early‐onset Parkinson's disease with PINK1 mutations (n = 10), early‐onset Parkinson's disease without PINK1 mutations (n = 10), and healthy sex‐ and age‐matched subjects (n = 20). We measured peak areas of phosphocreatine and beta adenosine triphosphate. Results The EOPD‐ group had normal PCr + βATP contents at rest (P = NS) and under activation (P = NS), but reduced contents during recovery (P < 0.001). The EOPD+ group had abnormal PCr + βATP contents at rest (P < 0.001) and during activation (P < 0.001); during recovery, the contents only partially recovered (P < 0.001). Brain intracellular pH alterations were more severe with EOPD+ than with EOPD−. Conclusions Brain mitochondrial impairments were similar in early‐onset Parkinson's disease without PINK1 mutations and late‐onset Parkinson's disease. However, mitochondrial impairments were more severe in early‐onset Parkinson's disease with PINK1 mutations. © 2020 International Parkinson and Movement Disorder Society |
Author | Dossi, Gabriele Rango, Mario Squarcina, Letizia Bonifati, Cristiana |
Author_xml | – sequence: 1 givenname: Mario surname: Rango fullname: Rango, Mario email: mariocristia@yahoo.it organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan – sequence: 2 givenname: Gabriele surname: Dossi fullname: Dossi, Gabriele organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan – sequence: 3 givenname: Letizia surname: Squarcina fullname: Squarcina, Letizia organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan – sequence: 4 givenname: Cristiana surname: Bonifati fullname: Bonifati, Cristiana organization: Fondazione IRCCS Cà Granda Maggiore Policlinico Hospital, University of Milan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31898835$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUlOxDAQRS0EopthwQVQJBbAImDH8ZAlMy2aQQLWluO4hSGxGzsR6h1H4IycBPe0QbAqVfn9r3L9DbBqndUA7CB4hCDMjpsqHGWsyOkK6COCUcozwlZBH3JOUow46YGNEF4hRIggug56cVZwjkkflKdeGps0pnXqxdnKG1knphlL4xtt2yS-aenryffnl7NBt8mD9G_GBmf3Q1KZoGXQyYdpXxLnZ9V1kRnc3aCk6VrZGme3wNpI1kFvL-omeL68eDq7Tof3V4Ozk2GqMME05ZQqLnnOFOUVhWXOWIErLWVJIWGaqqyCRcFKiQiDpaK0ynDO8pGihYodwZvgYO479u6906EVjQlK17W02nVBZBhjCnFW5BHd-4W-us7buF2kGM0pKfKp4e6C6spGV2LsTSP9RCyvF4HjOaC8C8HrkVBm_uc2XrUWCIppPiLmI2b5RMXhL8XS9C924f5haj35HxS3549zxQ-wC59T |
CitedBy_id | crossref_primary_10_1016_j_arr_2023_102090 crossref_primary_10_1016_j_nbd_2020_105246 crossref_primary_10_1016_S1474_4422_21_00061_2 crossref_primary_10_1021_acschemneuro_3c00216 crossref_primary_10_3389_fnins_2021_660379 crossref_primary_10_3390_antiox12071411 crossref_primary_10_1016_j_bbabio_2022_148588 crossref_primary_10_1016_j_peptides_2021_170713 crossref_primary_10_12677_acm_2025_153781 crossref_primary_10_3390_ijms23137263 crossref_primary_10_1016_j_prp_2023_155023 crossref_primary_10_3389_fnins_2023_1116111 crossref_primary_10_1016_j_nbd_2020_105056 crossref_primary_10_3390_genes13030479 crossref_primary_10_1038_s41573_024_01105_0 crossref_primary_10_1016_j_arr_2024_102488 crossref_primary_10_1186_s10020_021_00426_9 crossref_primary_10_3389_fnagi_2021_690632 crossref_primary_10_1212_WNL_0000000000201288 crossref_primary_10_1002_ana_26884 crossref_primary_10_3389_fnins_2021_655901 crossref_primary_10_1155_2023_7759053 |
Cites_doi | 10.1111/j.1468-1331.2008.02514.x 10.1242/jcs.078303 10.1002/ana.410320721 10.1016/S1474-4422(06)70411-2 10.1097/00004647-200101000-00011 10.1016/S1474-4422(06)70471-9 10.1111/apha.13068 10.1136/jnnp.55.3.181 10.1016/j.mito.2012.10.004 10.1007/s00415-011-6392-3 10.1017/cjn.2015.244 10.1038/sj.jcbfm.9600192 10.1038/jcbfm.1989.2 10.1016/j.parkreldis.2013.06.009 10.1152/advan.00045.2004 10.1016/j.sleep.2007.07.004 10.1016/j.neurobiolaging.2018.10.030 10.1002/ana.410280510 10.1073/pnas.0802076105 10.1126/science.3260686 10.1212/01.wnl.0000167546.39375.82 10.1016/j.neuro.2005.08.006 10.1212/01.WNL.0000163999.72864.FD 10.1111/jnc.13731 10.1002/mrm.1910380605 10.1002/mdc3.12501 10.1002/humu.20719 10.1073/pnas.1107332108 10.1016/j.parkreldis.2006.08.009 10.1212/WNL.17.5.427 |
ContentType | Journal Article |
Copyright | 2020 International Parkinson and Movement Disorder Society 2020 International Parkinson and Movement Disorder Society. |
Copyright_xml | – notice: 2020 International Parkinson and Movement Disorder Society – notice: 2020 International Parkinson and Movement Disorder Society. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
DOI | 10.1002/mds.27946 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Nursing & Allied Health Premium MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8257 |
EndPage | 507 |
ExternalDocumentID | 31898835 10_1002_mds_27946 MDS27946 |
Genre | shortCommunication Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3536-866c8a847c68d60b47793deaab6057e6c2d0997ba1570bc66d23474fc69cc6653 |
IEDL.DBID | DR2 |
ISSN | 0885-3185 1531-8257 |
IngestDate | Fri Jul 11 07:35:18 EDT 2025 Sun Jul 13 05:32:44 EDT 2025 Mon Jul 21 05:56:10 EDT 2025 Thu Apr 24 23:08:26 EDT 2025 Tue Jul 01 01:44:25 EDT 2025 Wed Jan 22 16:34:48 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | brain pH brain mitochondrial functioning phosphorus magnetic resonance spectroscopy (MRS) early-onset Parkinson's disease (EOPD) PINK1 gene mutation |
Language | English |
License | 2020 International Parkinson and Movement Disorder Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3536-866c8a847c68d60b47793deaab6057e6c2d0997ba1570bc66d23474fc69cc6653 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 31898835 |
PQID | 2376465945 |
PQPubID | 1016421 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_2333603294 proquest_journals_2376465945 pubmed_primary_31898835 crossref_citationtrail_10_1002_mds_27946 crossref_primary_10_1002_mds_27946 wiley_primary_10_1002_mds_27946_MDS27946 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2020 2020-03-00 20200301 |
PublicationDateYYYYMMDD | 2020-03-01 |
PublicationDate_xml | – month: 03 year: 2020 text: March 2020 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | Movement disorders |
PublicationTitleAlternate | Mov Disord |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2004; 302 2017; 4 2019; 75 2004; 28 2018; 223 1989; 9 2008; 9 2006; 5 2005; 64 2005; 65 2008; 105 1988; 241 2017; 132 1992; 32 1992; 55 2007; 13 2001; 21 2013; 19 2011; 124 2011; 108 2013; 13 1990; 28 2006; 27 2008; 29 2006; 26 2016; 43 1967; 17 1997; 38 2016; 139 2012; 259 2009; 16 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 Valente EM (e_1_2_8_15_1) 2004; 302 |
References_xml | – volume: 32 start-page: S125 issue: S1 year: 1992 end-page: S127 article-title: Criteria for diagnosing Parkinson's disease publication-title: Ann Neurol – volume: 43 start-page: 113 issue: 1 year: 2016 end-page: 119 article-title: Early‐onset vs. Late‐onset Parkinson's disease: A Clinical‐pathological Study publication-title: Can J Neurol Sci – volume: 132 year: 2017 – volume: 28 start-page: 661 issue: 5 year: 1990 end-page: 667 article-title: Brain pH in head injury: an image‐guided 31P magnetic resonance spectroscopy study publication-title: Ann Neurol – volume: 9 start-page: 684 issue: 6 year: 2008 end-page: 688 article-title: Sleep quality in a family with hereditary parkinsonism (PARK6) publication-title: Sleep Med – volume: 139 start-page: 216 year: 2016 end-page: 231 article-title: Mitochondrial dysfunction in Parkinson's disease publication-title: J Neurochem – volume: 105 start-page: 11364 issue: 32 year: 2008 end-page: 11369 article-title: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress publication-title: Proc Natl Acad Sci U S A – volume: 108 start-page: 12920 issue: 31 year: 2011 end-page: 12924 article-title: Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission publication-title: Proc Natl Acad Sci – volume: 17 start-page: 427 issue: 5 year: 1967 end-page: 442 article-title: Parkinsonism: onset, progression and mortality publication-title: Neurology – volume: 9 start-page: 2 issue: 1 year: 1989 end-page: 19 article-title: ATP and brain function publication-title: J Cereb Blood Flow Metab – volume: 13 start-page: 359 issue: 6 year: 2007 end-page: 361 article-title: Novel features in a patient homozygous for the L347P mutation in the PINK1 gene publication-title: Parkinsonism Relat Disord. – volume: 75 start-page: 224.e9 year: 2019 end-page: 224.e15 article-title: Genetic variants of PARK genes in Korean patients with early‐onset Parkinson's disease publication-title: Neurobiol Aging – volume: 5 start-page: 525 issue: 6 year: 2006 end-page: 535 article-title: Epidemiology of Parkinson's disease publication-title: Lancet Neurol – volume: 55 start-page: 181 issue: 3 year: 1992 end-page: 184 article-title: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico‐pathological study of 100 cases publication-title: J Neurol Neurosurg Psychiatry – volume: 5 start-page: 355 issue: 4 year: 2006 end-page: 363 article-title: Epidemiological, clinical, and genetic characteristics of early‐onset parkinsonism publication-title: Lancet Neurol – volume: 223 issue: 3 year: 2018 article-title: Roles of pH in control of cell proliferation publication-title: Acta Physiol – volume: 16 start-page: 450 issue: 4 year: 2009 end-page: 456 article-title: The effect of onset age on the clinical features of Parkinson's disease publication-title: Eur J Neurol – volume: 13 start-page: 59 issue: 1 year: 2013 end-page: 61 article-title: PINK1 parkinsonism and Parkinson disease: distinguishable brain mitochondrial function and metabolomics publication-title: Mitochondrion – volume: 64 start-page: 1958 issue: 11 year: 2005 end-page: 1960 article-title: The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease publication-title: Neurology – volume: 241 start-page: 462 issue: 4864 year: 1988 end-page: 464 article-title: Nonoxidative glucose consumption during focal physiologic neural activity publication-title: Science – volume: 65 start-page: 87 issue: 1 year: 2005 end-page: 95 article-title: Early‐onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes publication-title: Neurology – volume: 27 start-page: 164 issue: 2 year: 2006 end-page: 168 article-title: Parkinson's disease, chronic hydrocarbon exposure and striatal neuronal damage: a 1‐H MRS study publication-title: Neurotoxicology – volume: 19 start-page: 961 issue: 11 year: 2013 end-page: 965 article-title: Gender and onset age‐related features of non‐motor symptoms of patients with Parkinson's disease ‐ A study from Southwest China publication-title: Park Relat Disord – volume: 302 start-page: 819 issue: 5646 year: 2004 end-page: 822 article-title: Molecular pathways of neurodegeneration in Parkinson's disease publication-title: Science – volume: 28 start-page: 160 issue: 4 year: 2004 end-page: 179 article-title: Regulation of intracellular pH publication-title: Adv Physiol Educ – volume: 29 start-page: 565 issue: 4 year: 2008 end-page: 565 article-title: PINK1 heterozygous rare variants: prevalence publication-title: significance and phenotypic spectrum. Hum Mutat – volume: 21 start-page: 85 issue: 1 year: 2001 end-page: 91 article-title: Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study publication-title: J Cereb Blood Flow Metab – volume: 259 start-page: 1639 issue: 8 year: 2012 end-page: 1647 article-title: Gender‐related differences in the burden of non‐motor symptoms in Parkinson's disease publication-title: J Neurol – volume: 26 start-page: 283 issue: 2 year: 2006 end-page: 290 article-title: Parkinson's disease and brain mitochondrial dysfunction: a functional phosphorus magnetic resonance spectroscopy study publication-title: J Cereb Blood Flow Metab. – volume: 38 start-page: 878 issue: 6 year: 1997 end-page: 883 article-title: Energetics of 3.5 s neural activation in humans: a 31P MR spectroscopy study publication-title: Magn Reson Med. – volume: 4 start-page: 499 issue: 4 year: 2017 end-page: 508 article-title: Genetic Identification in Early Onset Parkinsonism among Norwegian Patients publication-title: Mov Disord Clin Pract – volume: 124 start-page: 1115 issue: 7 year: 2011 end-page: 1125 article-title: Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance publication-title: J Cell Sci – ident: e_1_2_8_6_1 doi: 10.1111/j.1468-1331.2008.02514.x – ident: e_1_2_8_17_1 doi: 10.1242/jcs.078303 – ident: e_1_2_8_2_1 doi: 10.1002/ana.410320721 – ident: e_1_2_8_5_1 doi: 10.1016/S1474-4422(06)70411-2 – ident: e_1_2_8_24_1 doi: 10.1097/00004647-200101000-00011 – ident: e_1_2_8_4_1 doi: 10.1016/S1474-4422(06)70471-9 – ident: e_1_2_8_29_1 doi: 10.1111/apha.13068 – ident: e_1_2_8_19_1 doi: 10.1136/jnnp.55.3.181 – ident: e_1_2_8_18_1 doi: 10.1016/j.mito.2012.10.004 – ident: e_1_2_8_3_1 doi: 10.1007/s00415-011-6392-3 – ident: e_1_2_8_7_1 doi: 10.1017/cjn.2015.244 – ident: e_1_2_8_13_1 doi: 10.1038/sj.jcbfm.9600192 – ident: e_1_2_8_25_1 doi: 10.1038/jcbfm.1989.2 – ident: e_1_2_8_8_1 doi: 10.1016/j.parkreldis.2013.06.009 – ident: e_1_2_8_28_1 doi: 10.1152/advan.00045.2004 – ident: e_1_2_8_32_1 doi: 10.1016/j.sleep.2007.07.004 – ident: e_1_2_8_10_1 doi: 10.1016/j.neurobiolaging.2018.10.030 – ident: e_1_2_8_23_1 doi: 10.1002/ana.410280510 – ident: e_1_2_8_16_1 doi: 10.1073/pnas.0802076105 – ident: e_1_2_8_26_1 doi: 10.1126/science.3260686 – ident: e_1_2_8_14_1 doi: 10.1212/01.wnl.0000167546.39375.82 – volume: 302 start-page: 819 issue: 5646 year: 2004 ident: e_1_2_8_15_1 article-title: Molecular pathways of neurodegeneration in Parkinson's disease publication-title: Science – ident: e_1_2_8_21_1 doi: 10.1016/j.neuro.2005.08.006 – ident: e_1_2_8_31_1 doi: 10.1212/01.WNL.0000163999.72864.FD – ident: e_1_2_8_11_1 doi: 10.1111/jnc.13731 – ident: e_1_2_8_22_1 doi: 10.1002/mrm.1910380605 – ident: e_1_2_8_12_1 – ident: e_1_2_8_9_1 doi: 10.1002/mdc3.12501 – ident: e_1_2_8_33_1 doi: 10.1002/humu.20719 – ident: e_1_2_8_27_1 doi: 10.1073/pnas.1107332108 – ident: e_1_2_8_30_1 doi: 10.1016/j.parkreldis.2006.08.009 – ident: e_1_2_8_20_1 doi: 10.1212/WNL.17.5.427 |
SSID | ssj0011516 |
Score | 2.426523 |
Snippet | Background
PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with... PINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with early-onset... BackgroundPINK1 mutations are likely to affect mitochondrial function. The objective of this study was to study brain mitochondrial function in patients with... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 504 |
SubjectTerms | Adenosine triphosphate Age of Onset Brain - diagnostic imaging brain mitochondrial functioning brain pH early‐onset Parkinson's disease (EOPD) Humans Intracellular Magnetic resonance spectroscopy Mitochondria Mitochondria - genetics Movement disorders Mutation Mutation - genetics Neurodegenerative diseases Parkinson Disease - complications Parkinson Disease - genetics Parkinson's disease pH effects Phosphocreatine phosphorus magnetic resonance spectroscopy (MRS) PINK1 gene mutation Protein Kinases - genetics PTEN-induced putative kinase |
Title | Brain mitochondrial impairment in early‐onset Parkinson's disease with or without PINK1 mutation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.27946 https://www.ncbi.nlm.nih.gov/pubmed/31898835 https://www.proquest.com/docview/2376465945 https://www.proquest.com/docview/2333603294 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VPaBeoNACCy1yUSV6yTbrVxJxKoWqgLYHaKUeKkV-rYRgs9Xu5sKJn8Bv5Jcw4zyq0lZCPSWRJ7Fjz9hjz8w3ALvcFM5nIU8mQtpE-tQnNuRkLhTB54pPfEzTOT7Rx2fy07k6X4G3XSxMgw_RH7iRZMT5mgTc2MX-FWjo1C-GnODRcf4lXy1SiL700FGo6MS0pyhEKkYId6hCKd_v37y-Ft1QMK_rq3HBOXoEF11TGz-T78N6aYfu5z8ojvf8l3V42Cqi7KDhnMewEqon8GDcmto3wL6j5BFsihKPM2TliVEZxVR-m9OBIsOyQODIf379JofsJaP46RhK9mbBWrMPo1NeNpvH66xGmo8nn0dsWjf2_004O_pwenictAkZEicUARdr7XKD65nTudeplRlKtw_GWNwUZUE77ikQ15qRylLrtPZcyExOnC4cPinxFFarWRWeA5toH_ArhbLWSTMaFUZkxlDyE40aES8GsNcNTelatHJKmvGjbHCWeYl9VsY-G8DrnvSygei4jWirG9-ylVIswdlValVINYCdvhjli4wmpgqzmmiE0KnghRzAs4Yv-lqQr4ocVVhsbBzdu6svx--_xpsX_0_6EtY4be6jw9sWrC7nddhGDWhpX0VW_wvKwwJD |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61RaJcKG-WluJWSOWSbdZ2nETiQinV9rE99CH1giK_VqrKZtF2c-HET-A38kuYcR5VoUiIUxJ5EjueGXvs8XwD8Jbr3LrUZ9FYSBNJF7vI-IzchcK7LOFjF9J0jo7V8FweXCQXC_C-jYWp8SG6DTfSjDBek4LThvT2DWroxF33OeGjL8I9yuhN-Qt2TzrwKDR1QuJTVKMkxAi3uEIx3-5evT0b_WFi3rZYw5SztwKf28bWJ02u-tXc9O2333Ac__dvHsHDxhZlH2rheQwLvnwC90eNt_0pmB3KH8EmqPQ4SJaOZJVRWOXljPYUGZZ5wkf--f0HncmeMwqhDtFkW9es8fww2uhl01m4Tiuk2T8-HLBJVR8BeAbne5_OPg6jJidDZEVC2MVK2UzjlGZV5lRsZIoK7rzWBtdFqVeWO4rFNXqQpLGxSjkuZCrHVuUWnxLxHJbKaelfAhsr5_EreWKMlXowyLVItab8JwqNIp734F3Lm8I2gOWUN-NLUUMt8wL7rAh91oPNjvRrjdJxF9Fay-CiUVQswQEWhSeXSQ82umJUMfKb6NJPK6IRQsWC57IHL2rB6GpBwcoztGKxsYG9f6--GO2ehptX_076BpaHZ6Oj4ghZswoPOK31w_m3NViazyr_Gg2iuVkPcv8L3ogGXQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcWt5dKGAQElyyzfqVRJyAsiqPrRBQqQekyK9IVdlstd1ceuIn8Bv5Jcw4D1QeEuKURJ7EjmfGHns83wA85qZwPgt5UglpE-lTn9iQk7tQBJ8rXvmYpnN2oPcP5ZsjdbQGz_pYmBYfYthwI82I4zUp-Kmvdn-Chs792ZgTPPoluCw1KgtZRB8G7Ci0dGLeUyxQMUS4hxVK-e7w6sXJ6DcL86LBGmec6RZ87tvaHjQ5GTcrO3bnv8A4_ufPXIXNzhJlz1vRuQZrob4OG7PO134D7AvKHsHmqPI4RNaeJJVRUOXxknYUGZYFQkf-_vUbncheMQqgjrFkT85Y5_dhtM3LFst4XTRI8_rg7YTNm_YAwE04nL769HI_6TIyJE4oQi7W2uUGJzSnc69TKzNUbx-MsbgqyoJ23FMkrjUTlaXWae25kJmsnC4cPilxC9brRR22gVXaB_xKoax10kwmhRGZMZT9RKNJxIsRPO1ZU7oOrpyyZnwpW6BlXmKflbHPRvBoID1tMTr-RLTT87fs1BRLcHiVWhVSjeDhUIwKRl4TU4dFQzRC6FTwQo7gdisXQy0oV0WONiw2NnL379WXs72P8ebOv5M-gI33e9PyHXLmLlzhtNCPh992YH21bMI9tIZW9n6U-h_n5QUV |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+Mitochondrial+Impairment+in+Early%E2%80%90Onset+Parkinson%27s+Disease+With+or+Without+PINK1+Mutation&rft.jtitle=Movement+disorders&rft.au=Rango%2C+Mario&rft.au=Dossi%2C+Gabriele&rft.au=Squarcina%2C+Letizia&rft.au=Bonifati%2C+Cristiana&rft.date=2020-03-01&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=35&rft.issue=3&rft.spage=504&rft.epage=507&rft_id=info:doi/10.1002%2Fmds.27946&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mds_27946 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |